[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361577-105":59,"doc-detail-361577-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","socioeconomic-disparities-in-sarcoma-diagnosis-expert-center-access-and-advocacy-group-awareness-a-multcenter-study-in-southern-europe","Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness - amulticenter study in Southern Europe","","Management of sarcoma in expert centers improves outcomes, and patient advocacy groups offer information, support, and representation; however, access to both remains uneven. A survey-based multicenter study assessed factors linked to referral and advocacy group awareness in Spain and Portugal, two universal healthcare systems with distinct sarcoma pathways. Between April–December 2023, adults under treatment or follow-up were analyzed across 9 Spanish hospitals and 1 Portuguese hospital.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/socioeconomic-disparities-in-sarcoma-diagnosis-expert-center-access-and-advocacy-group-awareness-a-multcenter-study-in-southern-europe/361577/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/socioeconomic-disparities-in-sarcoma-diagnosis-expert-center-access-and-advocacy-group-awareness-a-multcenter-study-in-southern-europe/361577.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study aiming to identify regarding sarcoma care?","Question",{"text":112,"@type":113},"The study aimed to identify factors associated with patient referral and advocacy group awareness in Spain and Portugal, focusing on how these vary across socioeconomic and pathway-related factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many patients were included, and from which settings?",{"text":117,"@type":113},"A total of 415 patients were included: 365 from Spain and 50 from Portugal, with recruitment across 9 Spanish hospitals (including 5 expert centers) and 1 Portuguese hospital.",{"name":119,"@type":110,"acceptedAnswer":120},"Which patient factors were linked to diagnostic delays and advocacy group awareness?",{"text":121,"@type":113},"Lower income was associated with longer diagnostic delays and lower cancer advocacy group awareness, while longer diagnostic delays were associated with higher advocacy group awareness; sarcoma-specific awareness was generally low overall.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361577,1791023806,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","The Oncologist, 2026, 31, oyag358  \n[https://doi.org/10.1093/oncolo/oyag358](https://doi.org/10.1093/oncolo/oyag358)  \n[Published: September 7](Published: September 7), 2026  \nOriginal Article  \nSocioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: amulticenter study in Southern Europe  \nPau Mascar-Baselga1, , V ctor Navarro2, , Ana Sebio3, , Rosa lvarez4, , Sara Carvalho5, , Mar a ngeles Sala-Gonzlez6, , Gloria Marquina7, , Javier Mart nez-Trufero8, , Juana Mar a Cano9, , Andrés Redondo10, Aurea Molina-D az11, , Diego Gomez-Puerto1, , Carlo Mar a Cicala1, ,  \nMiguel Henriques-Abreu5, Claudia Valverde1, , Guillermo Villacampa2, , César Serrano*,1,   \n1 Medical Oncology Department, Vall d’Hebron University Hospital – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain 2Statistics Unit, Vall d0 Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain  \n3 Medical Oncology Department, Santa Creu i Sant Pau Hospital, Barcelona, 08025, Spain  \n4 Medical Oncology Department, Instituto de Investigacin Sanitaria Gregorio Mara~nn, Gregorio Mara~non University Hospital, Madrid, 28007, Spain 5 Medical Oncology Department, Portuguese Institute of Oncology of Porto Francisco Gentil, Porto, 4200-072, Portugal  \n6 Medical Oncology Department, Basurto University Hospital, Bilbao, 48013, Spain  \n7 Medical Oncology Department, Cl San Carlos University Hospital. Universidad Complutense de Madrid (UCM), Instituto de Investigacin Sanitaria (IdISSC), EURACAN Referral Center, Madrid, 28040, Spain  \n8 Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, 50009, Spain 9 Medical Oncology Department, Ciudad Real General University Hospital, Ciudad Real, 13005, Spain 10 Medical Oncology Department, La Paz University Hospital, Madrid, 28046, Spain  \n11 Medical Oncology Department, A Coru ~na University Hospital Complex (CHUAC), A Coru~na, 15006, Spain  \n*Corresponding author: César Serrano, MD, PhD, Sarcoma Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035 Barcelona, Spain ([cserrano@vhio. net](cserrano@vhio. net)) .  \nAbstract  \nBackground: Management of sarcoma in expert centers (SECs) improves outcomes, and patient advocacy groups provide information, support, and representation of patients’ needs; however, access to both remains uneven. We aimed to identify factors associated with patient referral and advocacy group awareness in Spain and Portugal, 2 universal healthcare systems with distinct sarcoma pathways.  \nMaterials and Methods: Between April and December 2023, we conducted a survey-based study of adults with sarcoma under active treatment or follow-up across 9 Spanish hospitals (5 SECs) and one Portuguese hospital. Sociodemographic and clinical data, referral patterns, and advocacy group awareness/contact were analyzed.  \nResults: A total of 415 patients were included (Spain, n = 365; Portugal, n = 50). In Spain, lower income (odds ratio [OR] 2.38; 95% CI, 1.16-5.03) was associated with longer diagnostic delays. Rural residence (OR 3.48; 1.79-7.04) and longer diagnostic delays (OR 2.41; 1.26-4.66) were associated with referral to other hospitals. Cancer advocacy group awareness was lower among patients with lower income (OR 0.38; 0.17-0.81) and higher with longer diagnostic delays (OR 2.08; 1.05-4.25). Sarcomaspecific advocacy group awareness was generally low (20%) but higher with university education (OR 4.27; 1.56-12.35). Few patients contacted cancer (14%) or sarcoma-specific groups (7%); contact was more frequent with longer diagnostic delays (OR 2.27; 1.11-4.63) or symptomatic presentation (OR 2.50; 1.04-5.97). Compared with the Portuguese cohort, Spanish patients were referred less frequently and had greater awareness of advocacy groups.  \nConclusion: Socioeconomic disparities affect sarcoma diagnosis, referral, and advocacy","cbCaiohJZveKqXpH","https://ap.wps.com/l/cbCaiohJZveKqXpH","pdf",1973219,12,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusion\n# Implications for practice\n# Introduction","[{\"question\":\"What was the study aiming to identify regarding sarcoma care?\",\"answer\":\"The study aimed to identify factors associated with patient referral and advocacy group awareness in Spain and Portugal, focusing on how these vary across socioeconomic and pathway-related factors.\"},{\"question\":\"How many patients were included, and from which settings?\",\"answer\":\"A total of 415 patients were included: 365 from Spain and 50 from Portugal, with recruitment across 9 Spanish hospitals (including 5 expert centers) and 1 Portuguese hospital.\"},{\"question\":\"Which patient factors were linked to diagnostic delays and advocacy group awareness?\",\"answer\":\"Lower income was associated with longer diagnostic delays and lower cancer advocacy group awareness, while longer diagnostic delays were associated with higher advocacy group awareness; sarcoma-specific awareness was generally low overall.\"}]","Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness - amulticenter study in Southern Europe | PDF",1790144918,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de515592cef8703ab4727cbd70bc2b2c.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f20fec64ec386e6bed360c32a7f580c2.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95c154162beb5e687025de42787d6d73.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fd6b69fce42c10328b8c532671d7e2f.webp",980,1287]